Next-generation analytics in viral vector manufacturing

Webinar On Demand

Viral vectors that are used in gene therapies and gene-modified cell therapies face complex analytical challenges, requiring indirect and direct measurement methods and high-quality reagents. That’s why it’s crucial to develop standardized and validated analytical methods, reference standards, and reagents to ensure viral vector analysis accuracy, reproducibility, and comparability across applications. By addressing these analytical challenges, next-generation analytics can accelerate the development and translation of safe and effective viral vector-based gene therapies for patients.

Watch Thermo Fisher Scientific’s on-demand webinar, “Next-generation analytics in viral vector manufacturing” to learn:

  • The roles for analytics in the production of viral vectors for gene therapies and gene-modified cell therapies
  • Current challenges related to traditional analytical methods for determining viral vector quality and characterization
  • Case studies showing how the next generation is addressing challenges in adeno-associated viruses and lentiviruses
  • Challenges and considerations associated with new technology adoption and the future of viral vector analytics